Literature DB >> 9207585

Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.

P I Pakarinen1, J Suvisaari, T Luukkainen, P Lähteenmäki.   

Abstract

OBJECTIVE(S): To study the prevalence of persisting ovarian follicles and to assess the endometrial changes and patterns of vaginal bleeding over 1 year of use of a 20 micrograms/24 h levonorgestrel-releasing intracervical contraceptive device.
DESIGN: Prospective, randomized study.
SETTING: Two family planning clinics in Helsinki, Finland. PATIENT(S): Women requesting intrauterine hormonal contraception. INTERVENTION(S): Insertion of a levonorgestrel-releasing intracervical contraceptive device into the cervical canal (group 1, n = 151) or fundally into the uterine cavity (group 2, n = 147) for contraception. MAIN OUTCOME MEASURE(S): Transvaginal ultrasonography of the ovaries and endometrium at insertion and 3, 6, and 12 months after insertion. Data on bleeding were collected using menstrual diary cards.
RESULTS: Persisting ovarian follicles were found in < 8% of women. In both groups, the amount of endometrial tissue decreased significantly in 3 months. The incidence of amenorrhea during the 1st year was higher in the fundal insertion group. CONCLUSION(S): The number of persisting follicles was low. Follicles resolved within 6 to 8 weeks. No association was found between persisting follicles and problems of bleeding. Compared with intracervical insertion, fundal insertion resulted in more uniform endometrial suppression and fewer days of bleeding and spotting.

Entities:  

Keywords:  Biology; Clinical Research; Comparative Studies; Contraception; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Methods; Developed Countries; Endometrial Effects; Endometrium; Europe; Family Planning; Finland; Genitalia; Genitalia, Female; Insertion; Levonorgestrel--side effects; Menstrual Cycle; Menstruation; Northern Europe; Ovarian Effects; Ovary; Physiology; Prospective Studies; Reproduction; Research Methodology; Research Report; Scandinavia; Studies; Treatment; Urogenital System; Uterus

Mesh:

Substances:

Year:  1997        PMID: 9207585     DOI: 10.1016/s0015-0282(97)81476-8

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  3 in total

Review 1.  Recent developments in hormonal contraception.

Authors:  Eleanor A Drey; Philip D Darney
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

2.  Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.

Authors:  Tiina Backman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

3.  Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis.

Authors:  Jill E Sergison; Lauren Y Maldonado; Xiaoming Gao; David Hubacher
Journal:  Am J Obstet Gynecol       Date:  2018-12-07       Impact factor: 8.661

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.